Streetbeat News

Corporate Responsibility

VCYT

Veracyte, Inc. (NASDAQ:VCYT), a cancer diagnostics company, announced that nine abstracts on its Decipher Prostate and Decipher Bladder tests will be presented at AUA 2024. These studies highlight the clinical utility of these tests in treatment decisions and provide new insights into the biology of urologic cancers. The presentations at the American Urological Association meeting in San Antonio will cover various topics, including the risk of metastatic progression, genomic signatures, and the impact of genomic subtypes on prognosis.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 12:42 pm

PGY

Pagaya Technologies Ltd. (NASDAQ:PGY), a global technology company specializing in AI-driven financial solutions, announced the formation of a strategic Advisory Board chaired by Tami Rosen, who also transitions to Chief Development Officer. Rosen's role will focus on fostering strategic partnerships and connections to support Pagaya's growth and competitive advantage in the financial ecosystem. Rosen, with a notable career at companies like Apple and Goldman Sachs, aims to leverage her experience to drive innovation and long-term growth at Pagaya.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 12:41 pm

BA

Boeing Co. (NYSE:BA) has terminated its contract with Cornerstone Government Affairs, the lobbying firm that supported Boeing during the 737 Max crisis. This decision, made by Boeing's chief lobbyist Ziad "Z" Ojakli, aligns with the company's strategy to overhaul its leadership and lobbying efforts following the 737 Max incidents. Boeing's lobbying investment in 2023 amounted to $14.4 million with a significant lobbying team in place. The company's recent challenges include a decline in commercial aircraft deliveries and a safety incident involving a Delta Air Lines Boeing 757.

Portfolio Pulse from Benzinga Neuro

April 16, 2024 | 12:39 pm

PRPH

ProPhase Labs, Inc. (NASDAQ:PRPH) announced the launch of Project ZenQ-AI, a new initiative in cancer treatment research leveraging its AI platform, extensive genomics database, and patented insights into esophageal cancer for the development of Antibody Drug Conjugates (ADCs). The project aims to utilize whole genome sequencing data from over 130 countries and the BE-Smart Test for esophageal adenocarcinoma to identify ADC candidates, promising more effective and personalized cancer treatments.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 12:15 pm

GIL

Browning West, holding 5% of Gildan Activewear's shares, criticizes CEO Vince Tyra's strategy and governance, highlighting his track record of value destruction and underwhelming plans for the company. They propose electing eight new directors at the 2024 shareholder meeting to implement a value creation strategy, contrasting Tyra's approach with speculative spending and poor capital allocation. Browning West's plan aims to increase operating margins and shareholder returns, setting specific targets for share price growth.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 12:12 pm

IMCC

IM Cannabis Corp. (IMCC) has announced it will not complete the remaining installment payments for the 51% shares held by IMC Holdings Ltd., opting instead to return the shares to the seller. This decision is part of IMC's strategic shift to focus on the German market, especially following the legalization of cannabis in Germany on April 1st. The company aims to allocate resources to markets with the highest growth potential, notably Germany and Israel.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 12:10 pm

LSEA

Landsea Homes has introduced 'Landsea Elements', a suite of exclusive financial services aimed at providing end-to-end support for its homebuyers. This includes the launch of Landsea Insurance Agency, complementing the existing services of Landsea Mortgage and Landsea Title.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 12:07 pm

NSANY

TM

TSLA

Nissan Motor Co plans to adopt gigacasting, a technique popularized by Tesla Inc, to produce components for its electric vehicles, aiming to reduce manufacturing costs by 10% and achieve cost parity between electric and traditional vehicles by 2030. This move is part of Nissan's strategy to enhance competitiveness in the EV market. Toyota Motor Corp has also committed to adopting gigacasting, indicating its industry-wide appeal.

Portfolio Pulse from Shivani Kumaresan

April 16, 2024 | 12:06 pm

CRL

Charles River Laboratories has initiated the Alternative Methods Advancement Project aimed at reducing reliance on animal testing. This move reflects the company's commitment to more ethical and sustainable research practices. It could potentially enhance the company's reputation and appeal to investors interested in corporate responsibility.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 12:04 pm